Memorializing Governor Kathy Hochul to proclaim May 11-17, 2025, as Fibromyalgia Awareness Week in the State of New York
Assembly Resolution No. 484 is a nonbinding memorializing resolution that asks Governor Kathy Hochul to proclaim May 11-17, 2025, as Fibromyalgia Awareness Week in New York State. The resolution describes fibromyalgia as a chronic syndrome affecting millions of people, characterized by widespread pain, fatigue, sleep disturbance, cognitive issues, and other symptoms, and emphasizes that it has no known cure and is often difficult to diagnose and treat. It also highlights the need for greater public awareness, physician education, research funding, and support for patients and families.
The resolution further frames fibromyalgia as a condition with significant social and economic consequences, including delayed diagnosis, workplace misunderstanding, lost employment opportunities, and high out-of-pocket medical costs. It references the work of the Fibromyalgia Task Force of New York State and related advocacy organizations, and encourages support for prevention, treatment, and a cure. Because it is a resolution rather than a statute, it does not create new legal rights or mandates; instead, it seeks an official state proclamation and transmits copies to state health and medical institutions and advocacy groups.
This resolution would not amend the New York Consolidated Laws or impose regulatory requirements. Its legal effect is limited to expressing the Legislature’s support for recognizing Fibromyalgia Awareness Week and requesting a gubernatorial proclamation. The practical impact is symbolic and educational: it elevates awareness among state agencies, medical professionals, and the public, and may help support advocacy for research, diagnosis, accommodations, and treatment resources for people living with fibromyalgia.
The overall sentiment is strongly supportive and sympathetic toward people with fibromyalgia. The resolution presents the condition as serious, underrecognized, and deserving of greater attention from the medical community, employers, educators, and the public. No opposition, negative votes, or committee objections are reflected in the provided record, and the tone is one of recognition, advocacy, and encouragement for further research and awareness.
There is little direct contention in the bill text or available legislative history because no committee transcripts or votes are provided. The only implied points of debate are policy-oriented rather than partisan: the resolution argues that fibromyalgia is underdiagnosed, insufficiently taught in medical schools, and inadequately accommodated in workplaces, and it suggests a need for more research, physician education, and possibly more formal recognition of disability-related impacts. Any disagreement would likely center on the extent of state attention or resources devoted to awareness and research rather than on the resolution’s ceremonial proclamation itself.